|
Volumn 1, Issue 3, 2011, Pages 183-184
|
Advances in vaginal drug delivery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRACEPTIVE AGENT;
DAPIVIRINE;
DIETHYLENETRIAMINE;
ETHINYLESTRADIOL PLUS ETONOGESTREL;
ETHYLENE VINYL ACETATE COPOLYMER;
GESTAGEN;
LEVONORGESTREL;
MICROBICIDE;
N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE;
NANOPARTICLE;
NITRIC OXIDE;
NONOXINOL 9;
POLYMER;
POLYURETHAN;
SILICONE;
TENOFOVIR;
CHLAMYDIASIS;
DEVICE SAFETY;
DRUG ADMINISTRATION ROUTE;
DRUG DELIVERY SYSTEM;
EDITORIAL;
FILM;
GEL;
GONORRHEA;
HIGH RISK POPULATION;
HORMONE SUBSTITUTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PREGNANCY;
PRIORITY JOURNAL;
SEXUAL BEHAVIOR;
SEXUALLY TRANSMITTED DISEASE;
SYPHILIS;
TRICHOMONIASIS;
VAGINA;
VAGINA PESSARY;
WORLD HEALTH ORGANIZATION;
|
EID: 84862984369
PISSN: 2190393X
EISSN: 21903948
Source Type: Journal
DOI: 10.1007/s13346-011-0030-6 Document Type: Editorial |
Times cited : (11)
|
References (7)
|